Paid Clinical Trials Norman
Discover 727 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Sponsor:
Chimerix
Location:
Code:
NCT05580562
Conditions
H3 K27M
Glioma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Dordaviprone (ONC201)
Dordaviprone (ONC201) + Placebo
Placebo
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C MutationA Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
Sponsor:
Genentech, Inc.
Location:
Code:
NCT04449874
Conditions
Non-Small Cell Lung Cancer
Colorectal Cancer
Advanced Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GDC-6036
Atezolizumab
Cetuximab
Bevacizumab
Erlotinib
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionAGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Sponsor:
AbbVie
Location:
Code:
NCT04499248
Conditions
Open-angle Glaucoma
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AGN-193408 SR
Lumigan
Sham Administration
Lumigan Vehicle
Spirometric Response to Bronchial Thermoplasty in Patients With Severe AsthmaSpirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
Sponsor:
University of Oklahoma
Location:
Code:
NCT02241265
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT06003426
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
BMS-986278
BMS-986278 Placebo
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideAndrogen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide
Sponsor:
Alliance Foundation Trials, LLC.
Location:
Code:
NCT04335682
Conditions
Metastatic Prostate Cancer
Prostate Cancer Metastatic
Prostate Cancer
Castrate Resistant Prostate Cancer
Hormone Sensitive Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Darolutamide
Enzalutamide
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06293365
Conditions
Sjögrens Disease
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
VAY736 1ml PFS
VAY736 2 ml PFS
VAY736 2ml AI
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaA Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Sponsor:
Washington University School of Medicine
Location:
Code:
NCT05903131
Conditions
Endometrial Hyperplasia
Grade 1 Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Telemedicine behavioral weight intervention
Progestin
Enhanced usual care
Levonorgestrel-releasing IUD.
Abbott Ventricular Tachycardia PASAbbott Ventricular Tachycardia PAS
Sponsor:
Abbott Medical Devices
Location:
Code:
NCT05839873
Conditions
Ventricular Tachycardia
Eligibility Criteria
Sex: All
Age: 7+
Healthy Volunteers: Not accepted
Interventions
FlexAbility SE Ablation Catheter